Cadwell Industries Appoints Jeff Cohen as New CEO Following a Decade of Leadership by Patrick Jensen
Transition in Leadership at Cadwell Industries
Cadwell Industries, Inc. has announced a significant leadership change with the appointment of Jeff Cohen as their new Chief Executive Officer, succeeding the long-serving Patrick Jensen, Ph.D. Jensen will conclude his 10-year tenure while remaining involved as a strategic advisor to ensure a smooth transition.
The news, announced on September 10, 2026, has prompted reflections on the impactful decade Jensen spent at the helm of Cadwell. During his time, Jensen was instrumental in expanding the company’s influence in the neurodiagnostic space, guided by a commitment to serving both clinicians and their patients. His leadership saw Cadwell broaden its market reach and strengthen its capabilities in epilepsy monitoring while also enhancing its innovation portfolio with impactful new products.
Chairman of the Board John Cadwell Jr. commended Jensen for his decade of dedicated leadership, stating, "He oversaw tremendous growth during his tenure while maintaining Cadwell's motto of, 'Helping you help others.'" Jensen’s proactive approach toward family commitments prompted his decision to step back, which he communicated to the Board about a year ago. The company is grateful for Jensen's direct engagement in finding Cohen as a successor, promoting a seamless transition, which underscores a commitment to continuity and future advancement within the organization.
Reflecting on his accomplishments, Jensen noted, "I'm grateful to have worked with the Cadwell team and our amazing network of physicians and technicians over the past ten years. We have made significant progress towards our mission of improving the lives of neurology patients around the world." His confidence in Cohen as the right leader for the future speaks to the respect within Cadwell's ranks.
Cohen brings a wealth of experience, boasting over 20 years in the medical technology sector. His previous role at Philips saw him ascend from program manager to senior vice president and general manager of Philips Ultrasound, during which time he led teams to grow market share while improving profit margins. With an educational background that includes a bachelor’s degree in chemical engineering from Worcester Polytechnic Institute and an MBA from Boston College, Cohen is well-equipped to tackle the challenges ahead at Cadwell.
As Cohen steps into his new role, he expressed eagerness to build upon the solid foundation left by Jensen and the Cadwell team, stating, "It is an honor and privilege to lead Cadwell in the next phase of growth, carrying forward the company's strong legacy of helping neurology patients in their time of need." With this leadership change, Cadwell aims not only to innovate its neurodiagnostic offerings but also to expand its global footprint, solidifying its place as a comprehensive provider of key neurodiagnostic solutions.
Looking Forward
Cohen's leadership marks a pivotal moment for Cadwell as the company continues striving towards its ambitious vision: to support more patients worldwide than any other provider in the neurodiagnostics arena. With Jensen remaining on board as a strategic advisor, the potential for a seamless transition coupled with a renewed vision illustrates Cadwell’s commitment not only to its growth but to the well-being of the patients it serves. As the medical technology landscape evolves, the leadership at Cadwell promises to remain focused on its objectives, ensuring continual improvement in the care of neurology patients across the globe.
In sum, the transition from Patrick Jensen to Jeff Cohen not only symbolizes a new chapter in Cadwell’s journey but also reinforces the company’s dedication to innovation, patient care, and strategic growth in the neurodiagnostics market.